Insider · CIK 0001871714
Christopher Thomas Giordano
Files at TENX (TENAX THERAPEUTICS, INC.). First filing Nov 20, 2025, latest Sep 15, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TENX: TENAX THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | TENAX THERAPEUTICS, INC. | $20k 10,850 shares | +96% | - | |
| 48Moderate | TENAX THERAPEUTICS, INC. | $20k 2,605 shares | - | +61% from low-2% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stock | +6,000 | $1.88 | $11k | 17,324 | 27 d ago |
| Sep 15, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stock | +4,850 | $1.82 | $8,837 | 22,174 | 27 d ago |
| Nov 18, 2025 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stock | +1,612 | $7.75 | $13k | 1,612 | Nov 20, 2025 |
| Nov 19, 2025 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stock | +455 | $7.51 | $3,417 | 2,067 | Nov 20, 2025 |
| Nov 20, 2025 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stock | +538 | $7.59 | $4,083 | 2,605 | Nov 20, 2025 |
| May 16, 2025 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,400,000 | $0.00 | $0 | 1,400,000 | May 20, 2025 |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,250,000 | $0.00 | $0 | 1,250,000 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.